Login/Sign Up
₹593.6*
MRP ₹659.5
10% off
₹560.57*
MRP ₹659.5
15% CB
₹98.93 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Selected Pack Size:10
(₹59.36 per unit)
In Stock
(₹65.97 per unit)
In Stock
Online payment accepted
Whats That
About Ipca MMF-S Tablet
Ipca MMF-S Tablet belongs to a class of medications called ‘immunosuppressants’ used to prevent the body from rejecting a transplanted organ such as a kidney, heart or liver. Transplant rejection occurs when the recipient’s immune system identifies the transplanted organ as a ‘foreign object’ and attacks it. If it is not treated promptly, it may cause irreversible damage.
Ipca MMF-S Tablet contains ‘Mycophenolate sodium’ used in the treatment of organ transplant rejection along with another immunosuppressant and anti-inflammatory agent. It inhibits T and B lymphocytes (white blood cells that attack foreign cells) and suppresses antibodies' production (identify and kill foreign cells). These effects suppress the immune system so that the transplanted graft is not rejected.
You are advised to take Ipca MMF-S Tablet for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, you may experience certain common side-effects, such as diarrhoea, cough, muscle pain, low blood pressure, fever and respiratory infections. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking Ipca MMF-S Tablet for as long as your doctor has prescribed. To avoid recurring symptoms, do not stop it midway. Do not take Ipca MMF-S Tablet if you are pregnant or planning for pregnancy. Ipca MMF-S Tablet should not be taken by breastfeeding mothers as it passes into breast milk. Ipca MMF-S Tablet should not be given to children as safety and efficacy have not been established. Ipca MMF-S Tablet may make you more susceptible to infections, consult your doctor if you develop fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising. Avoid excessive exposure to sunlight, wear protective clothing, and use protective sunscreen with a high protection factor while using Ipca MMF-S Tablet . Do not contact anyone who has shingles, chickenpox, or measles. Do not take Ipca MMF-S Tablet if you are not using effective contraception.
Uses of Ipca MMF-S Tablet
Directions for Use
Medicinal Benefits
Ipca MMF-S Tablet contains ‘Mycophenolate sodium’ which belongs to the class of ‘immunosuppressants’. It is used to prevent organ transplant rejection. It reduces the activity of the immune system by inhibiting the action of white blood cells (responsible for immune reactions) in the body.
Storage
Drug Warnings
Do not take Ipca MMF-S Tablet if you are allergic to any immunosuppressant medicines or mycophenolate sodium. Let your doctor know before using Ipca MMF-S Tablet if you have liver or kidney problems, severe digestive issues, cancer, liver disease (such as hepatitis B, hepatitis C), current/past infections, rare genetic disorders (such as Lesch-Nyhan or Kelley-Seegmiller syndromes). Do not take Ipca MMF-S Tablet if you are pregnant or planning for pregnancy as Ipca MMF-S Tablet is a Pregnancy category risk D medicine which can cause serious congenital disabilities to the unborn baby. Ipca MMF-S Tablet should not be taken by breastfeeding mothers as it passes into breast milk. Pregnant women should use reliable forms of birth control while on treatment and for six weeks after stopping treatment with Ipca MMF-S Tablet . While taking Ipca MMF-S Tablet , do not contact anyone who has shingles, chickenpox, or measles. Ipca MMF-S Tablet causes dizziness and drowsiness, so drive with caution. Ipca MMF-S Tablet should not be given to children as safety and efficacy have not been established. Avoid consuming alcohol along with Ipca MMF-S Tablet as it could lead to increased dizziness. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Avoid excessive exposure to sunlight, wear protective clothing, and use protective sunscreen with a high protection factor while using Ipca MMF-S Tablet .
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
Drug-Diseases Interactions
Login/Sign Up
Ipca MMF-S Tablet belongs to the group of medications called ‘immunosuppressants’. It works by weakening the immune system by inhibiting the production of cells or antibodies that attack foreign cells. This effect helps in stopping the immune system from targeting and rejecting the transplanted organ.
Ipca MMF-S Tablet causes leukopenia (decreased number of white blood cells) and hence may make you more susceptible to infections. Consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising.
Diarrhoea might be a side-effect of Ipca MMF-S Tablet . Drink lots of fluids and eat food rich in fibre if you experience diarrhoea. If you find blood in stools (tarry stools) or if you experience prolonged diarrhoea consult your doctor. Do not take anti-diarrheal medicine on your own.
Ipca MMF-S Tablet can suppress the immune system and can increase the risk of skin cancer. So, it would be best if you avoid prolonged exposure to sunlight. Also, wear protective clothing covering your head, neck, arms and legs, and use a sunscreen lotion with a high SPF (sun protection factor).
Ipca MMF-S Tablet can suppress the immune system. You should not donate blood while using Ipca MMF-S Tablet and at least 60 days after stopping treatment as it makes you more prone to infections. Besides, men should not donate sperm while using Ipca MMF-S Tablet for at least 90 days after stopping the treatment.
Some medicines might absorb mycophenolate sodium delayed or absorbed fast if taken concomitantly such as antacids containing aluminium or magnesium, colestipol, cholestyramine or calcium-free phosphate binders. Before taking Ipca MMF-S Tablet , speak with your doctor about your ongoing medication list. Your doctor will decide whether they should be taken along with Ipca MMF-S Tablet or not.
The live vaccine may not work while on treatment with Ipca MMF-S Tablet . Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Organ transplant rejection: When you get a new organ transplanted into your body, your body recognizes it as a foreign element and tries to attack and reject it because it is not originally part of your body. So, immunosuppressant drugs are given to such patients to suppress the immune system, stopping it from attacking the newly transplanted organs. Warnings signs of rejection are flu-like symptoms such as chills, headache, nausea, or vomiting, fever higher than 100o F, newly found pain at the region of the transplanted organ, weight gain and fatigue.
Have a query?